Summary: Tonight's podcast is a review of AngioDynamics (ANGO) a stock that I actually purchased earlier today after selling some shares of my Meridian Biosciences (VIVO). I shall also briefly review a portion of my portfolio management strategy.
Summary: Tonight's podcast is a review of AngioDynamics (ANGO) a stock that I actually purchased earlier today after selling some shares of my Meridian Biosciences (VIVO). I shall also briefly review a portion of my portfolio management strategy.
